BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

635 related articles for article (PubMed ID: 34201952)

  • 1. Flavonoids in Skin Senescence Prevention and Treatment.
    Domaszewska-Szostek A; Puzianowska-Kuźnicka M; Kuryłowicz A
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34201952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Senolytics and Senostatics: A Two-Pronged Approach to Target Cellular Senescence for Delaying Aging and Age-Related Diseases.
    Kang C
    Mol Cells; 2019 Dec; 42(12):821-827. PubMed ID: 31838837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of cellular senescence in skin ageing: A notion of mosaic and therapeutic strategies.
    Toutfaire M; Bauwens E; Debacq-Chainiaux F
    Biochem Pharmacol; 2017 Oct; 142():1-12. PubMed ID: 28408343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxytocin alleviates cellular senescence through oxytocin receptor-mediated extracellular signal-regulated kinase/Nrf2 signalling.
    Cho SY; Kim AY; Kim J; Choi DH; Son ED; Shin DW
    Br J Dermatol; 2019 Dec; 181(6):1216-1225. PubMed ID: 30801661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging senolytic agents derived from natural products.
    Li W; Qin L; Feng R; Hu G; Sun H; He Y; Zhang R
    Mech Ageing Dev; 2019 Jul; 181():1-6. PubMed ID: 31077707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease.
    Hickson LJ; Langhi Prata LGP; Bobart SA; Evans TK; Giorgadze N; Hashmi SK; Herrmann SM; Jensen MD; Jia Q; Jordan KL; Kellogg TA; Khosla S; Koerber DM; Lagnado AB; Lawson DK; LeBrasseur NK; Lerman LO; McDonald KM; McKenzie TJ; Passos JF; Pignolo RJ; Pirtskhalava T; Saadiq IM; Schaefer KK; Textor SC; Victorelli SG; Volkman TL; Xue A; Wentworth MA; Wissler Gerdes EO; Zhu Y; Tchkonia T; Kirkland JL
    EBioMedicine; 2019 Sep; 47():446-456. PubMed ID: 31542391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Senescence and the SASP: many therapeutic avenues.
    Birch J; Gil J
    Genes Dev; 2020 Dec; 34(23-24):1565-1576. PubMed ID: 33262144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible role of ginsenoside Rb1 in skin wound healing via regulating senescent skin dermal fibroblast.
    Hou J; Kim S
    Biochem Biophys Res Commun; 2018 May; 499(2):381-388. PubMed ID: 29577907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting Senescent Cells: Possible Implications for Delaying Skin Aging: A Mini-Review.
    Velarde MC; Demaria M
    Gerontology; 2016; 62(5):513-8. PubMed ID: 27031122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A focused natural compound screen reveals senolytic and senostatic effects of
    Kim EJ; Woo J; Shin S; Choi H; Kim Y; Kim J; Kang C
    Anim Cells Syst (Seoul); 2022; 26(6):310-317. PubMed ID: 36605596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of senescence-associated secretory phenotype by knockdown of secreted frizzled-related protein 4 contributes to the prevention of skin aging.
    Takaya K; Asou T; Kishi K
    Aging (Albany NY); 2022 Sep; 14(20):8167-8178. PubMed ID: 36084952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promises and challenges of senolytics in skin regeneration, pathology and ageing.
    Pils V; Ring N; Valdivieso K; Lämmermann I; Gruber F; Schosserer M; Grillari J; Ogrodnik M
    Mech Ageing Dev; 2021 Dec; 200():111588. PubMed ID: 34678388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular senescence in bone.
    Farr JN; Khosla S
    Bone; 2019 Apr; 121():121-133. PubMed ID: 30659978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging Therapeutic Approaches to Target the Dark Side of Senescent Cells: New Hopes to Treat Aging as a Disease and to Delay Age-Related Pathologies.
    Khalil R; Diab-Assaf M; Lemaitre JM
    Cells; 2023 Mar; 12(6):. PubMed ID: 36980256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting cellular senescence based on interorganelle communication, multilevel proteostasis, and metabolic control.
    Cavinato M; Madreiter-Sokolowski CT; Büttner S; Schosserer M; Zwerschke W; Wedel S; Grillari J; Graier WF; Jansen-Dürr P
    FEBS J; 2021 Jun; 288(12):3834-3854. PubMed ID: 33200494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The power of proteomics to monitor senescence-associated secretory phenotypes and beyond: toward clinical applications.
    Basisty N; Kale A; Patel S; Campisi J; Schilling B
    Expert Rev Proteomics; 2020 Apr; 17(4):297-308. PubMed ID: 32425074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New agents that target senescent cells: the flavone, fisetin, and the BCL-X
    Zhu Y; Doornebal EJ; Pirtskhalava T; Giorgadze N; Wentworth M; Fuhrmann-Stroissnigg H; Niedernhofer LJ; Robbins PD; Tchkonia T; Kirkland JL
    Aging (Albany NY); 2017 Mar; 9(3):955-963. PubMed ID: 28273655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular Senescence: A Translational Perspective.
    Kirkland JL; Tchkonia T
    EBioMedicine; 2017 Jul; 21():21-28. PubMed ID: 28416161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic strategies targeting cellular senescence for cancer and other diseases.
    Wang X; Fukumoto T; Noma KI
    J Biochem; 2024 Apr; 175(5):525-537. PubMed ID: 38366629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A guide to senolytic intervention in neurodegenerative disease.
    Lee S; Wang EY; Steinberg AB; Walton CC; Chinta SJ; Andersen JK
    Mech Ageing Dev; 2021 Dec; 200():111585. PubMed ID: 34627838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.